Lung disease due to FLNA mutation improved after shunt closure for congenital heart disease. Mori S, Tanoue K, Shimizu H, Nagafuchi H, et al. Pediatr Pulmonol 2021 Jan 26. doi: 10.1002/ppul.25269.

Read + Share

Amedeo Smart

Independent Medical Education

Mori S, Tanoue K, Shimizu H, Nagafuchi H, et al. Lung disease due to FLNA mutation improved after shunt closure for congenital heart disease. Pediatr Pulmonol 2021 Jan 26. doi: 10.1002/ppul.25269.
PMID: 33497531